Chandy was the president of the Industrial Division of Pall Corporation, a leading supplier of filtration, separation, and purification technologies. Previously, she was chief marketing officer at the Dow Chemical Company and Rohm and Haas Corporation
The 15-year agreement will leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies
The SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets
Rapid testing produces air sample results in 30 minutes
New instrument helps maximize lab productivity and extends FTIR to large, heavy samples
It meets stringent requirements for ensuring the safe storage and efficacy of temperature-sensitive vaccines, including those for Covid-19
_256_384.jpg)
Closing the Loop on single-use plastics
Narayanan to lead SeQuent through next phase of consolidation and growth
PeproTech's recombinant proteins portfolio complements Thermo Fisher's cell culture media products
The TaqMan SARS CoV-2 Mutation Panel is compatible with real-time PCR instruments already commonly used in laboratories around the world
Subscribe To Our Newsletter & Stay Updated
